To cite this paper use one of the standards below:
INTRODUCTION: Fungal infections caused by resistant fungi have increased significantly in recent decades, becoming a global concern. The infection caused by the Candida genus called candidiasis is one of the main causes of morbidity and mortality caused by fungi in hospital environments and, in most cases, the Candida albicans species is the most common. The limited number of antifungal drug classes and the emergence of resistant species of C. albicans make treatment difficult. However, recent advances in antifungal drug development provide promising prospects for therapeutic approaches. Ellagic acid (EA) is a phenolic compound that has demonstrated antioxidant, anti-inflammatory and antimicrobial activity. However, its in vitro interaction with fluconazole (FLZ) against C. albicans needs to be further investigated. OBJECTIVE: To verify the antifungal activity of EA against C. albicans. METHODOLOGY: Two reference strains (C. albicans ATCC 90028 and C. albicans SC5314 ATCC MYA-2876) and nine clinical isolates from different anatomical sites, belonging to the culture collections of the Basic and Applied Immunology Center – NIBA of the Federal University of Maranhão - UFMA and the Microbiology, Bioprospecting and Biotechnology Research Laboratory – LPBIOTEC of the Federal Institute of Maranhão – IFMA were used for the Minimum Inhibitory Concentration (MIC), Minimum Fungicide Concentration (MFC) and in vitro interaction tests carried out through the test of Checkerboard. RESULTS: AE showed antifungal activity against all isolates tested, with MIC ranging from 250 – 1,000 μg / mL. Regarding the MFC of the AE, 63.6% of the samples had their activity classified as fungicidal. In the in vitro interaction test of AE with FLZ (EA+FLZ) it was demonstrated that 54.5% had a synergistic effect, 27.3% an additive effect and 18.2% an indifferent effect. CONCLUSION: It was demonstrated that EA has the potential to contribute to antifungal activity alone and combined with FLZ against C. albicans with synergistic and additive interactions, enhancing the antifungal effect of FLZ.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper